Enlivex

ENLV · NASDAQ

$0.2237−$0.0001 (−0.04%)TodayMarket closed ·
Prev close $0.2238

Latest news

  • Press releaseGlobe Newswire

    Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

  • NewsRishabh Mishra

    Stock Market: Will S&P 500 Open Up or Down Today?

  • Press releaseGlobe Newswire

    Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • Press releaseGlobe Newswire

    Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June

  • Press releaseGlobe Newswire

    Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results

  • NewsAvi Kapoor

    Dow Jumps 350 Points; Coca-Cola Shares Gain On Upbeat Earnings

  • Press releaseGlobe Newswire

    Enlivex Announces $400,000,000 Private Placement

  • Press releaseGlobe Newswire

    Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

  • Press releaseGlobe Newswire

    Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis

  • Press releaseGlobe Newswire

    Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026

  • Press releaseGlobe Newswire

    Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume

  • Press releaseGlobe Newswire

    Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

  • Press releaseGlobe Newswire

    Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • NewsVandana Singh

    Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum

  • NewsAvi Kapoor

    Dow Jumps 300 Points; Waldencast Shares Plunge

  • Press releasePRNewswire

    Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

  • NewsAvi Kapoor

    Nasdaq Surges 350 Points; Enlivex Therapeutics Shares Spike Higher

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • Press releaseGlobe Newswire

    Enlivex Issues Urgent Statement on Fraudulent News Dissemination

  • Press releaseACCESS Newswire

    RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.